Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide Combinations in Relapsed MM
NCT03440411Phase 3Terminated
- Sponsor
- Fondazione EMN Italy
- Start
- Feb 2016
- Primary completion
- Dec 2019
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 3 trial of pomalidomide in multiple myeloma (MM), sponsored by Fondazione EMN Italy. Started Feb 2016; status: terminated.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03440411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03440411.